All Topics
All Topics
Technology
Technology
AI
AI
Business
Business
Entertainment
Entertainment
News
News
Programming
Programming
Security
Security
Science
Science
Design
Design
Environment
Environment
Finance
Finance
Crypto
Crypto
Politics
Politics
Sports
Sports
Education
Education
Gaming
Gaming
Art
Art
Music
Music
Health
Health
Books
Books
Food
Food
Travel
Travel
Personal
Personal
Bluesky
Twitter

SNPnexus 2025 update: enhanced web platform for large-scale multi-sample genetic variant analysis

By

Oscanoa, Jorge, Zhu, Qianqian, Gadaleta, Emanuela, Chelala, Claude

9d ago· 12 min readenNews

Summary

SNPnexus, a web-based platform for functional annotation and prioritization of genetic variants, has undergone a major 2025 update. The update includes substantial backend re-engineering, performance improvements, complete restructuring of underlying datasets, and a redesigned interface that enables larger queries and multi-sample analysis. New capabilities support comparative workflows such as identifying shared pathogenic variants in disease cohorts and divergent mutations in cancer evolution studies, with increased processing capacity.

Source

bskySNPnexus 2025 update: enhanced web platform for large-scale multi-sample genetic variant analysisdoi.org

Key quotes

· 3 pulled
SNPnexus is a long-standing web-based platform for the functional annotation and prioritization of genetic variants.
Since its previous release, SNPnexus has undergone substantial backend re-engineering resulting in major performance improvements and a complete restructuring of the underlying datasets.
A redesigned interface now enables larger queries and multi-sample analysis enabling comparative workflows such as identifying shared pathogenic variants in disease cohorts and divergent mutations in cancer evolution studies.
Snippet from the RSS feed
Abstract. SNPnexus is a long-standing web-based platform for the functional annotation and prioritization of genetic variants. Since its previous release,

You might also wanna read

Comments

Sign in to join the conversation.

No comments yet. Be the first.